MGS Mfg. Group, Inc. has acquired Technolution A/S to enhance its capabilities in integrated manufacturing solutions for Pharma and MedTech applications.
Target Information
MGS Mfg. Group, Inc. is a global leader in integrated manufacturing solutions, specializing in high-precision plastic components for the healthcare and pharmaceutical industries. Recently, on May 31, 2023, MGS expanded its portfolio with the acquisition of Technolution A/S, a Danish consultancy and development firm focusing on Pharma and MedTech applications. This acquisition marks the fourth for MGS, which is part of the Mason Wells Buyout Fund IV, LP. Technolution's expertise in R&D, regulatory compliance, and project management complements MGS’s strengths in tooling, molding, and automation, creating a unique value proposition in the medical contract manufacturing landscape.
Industry Overview in Denmark
Denmark’s pharmaceutical industry is renowned for its innovation and high-quality production standards. The country is home to several leading global pharmaceutical companies and has a robust framework supporting research and development initiatives. This vibrant ecosystem is bolstered by strong regulatory support, facilitating the approval process for new drugs and medical devices.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
In recent years, the MedTech sector has witnessed accelerated growth, driven by advancements in technology and increased investment in health care solutions. Danish firms are focusing on creating integra
Similar Deals
Nordic Capital and Permira → Bavarian Nordic
2025
MGS Mfg. Group, Inc.
invested in
Technolution A/S
in 2023
in a Buyout deal